Texas Administrative Code
Title 22 - EXAMINING BOARDS
Part 9 - TEXAS MEDICAL BOARD
Chapter 198 - STANDARDS FOR USE OF INVESTIGATIONAL AGENTS
Subchapter B - INVESTIGATIONAL STEM CELL TREATMENTS FOR PATIENTS WITH CERTAIN SEVERE CHRONIC DISEASES OR TERMINAL ILLNESSES
Section 198.5 - Use of Investigational Stem Cell Treatments for Patients with Certain Severe Chronic Diseases or Terminal Illnesses

Universal Citation: 22 TX Admin Code § 198.5

Current through Reg. 49, No. 52; December 27, 2024

(a) The Legislature recognizes the need for patient access to innovative medical treatments. At the same time, the health and welfare of Texas citizens must be protected. These goals must be carefully balanced.

(b) The purpose of this subchapter is to set out the requirements for a patient to be eligible for consideration of receiving investigational stem cell treatment and under what circumstances a certified physician may administer or provide investigational stem cell treatments. The implementation of this rule is contingent upon qualifying chronic diseases or terminal illness being defined, as set out in § 1003.052 of the Texas Health and Safety Code.

(c) This rule does not require an eligible patient to receive such treatment, but rather the statute sets the eligibility standards and the parameters under which treatment may be provided to an individual with a qualifying severe chronic disease or terminal illness.

(d) Stem cell treatments which are under investigation in a clinical trial and being administered to human participants:

(1) may be administered or provided to eligible patients with qualifying terminal illnesses or severe chronic diseases as defined by the executive commissioner of the Health and Human Services Commission; and

(2) must be done in compliance with applicable law.

(e) In order for a patient to be eligible to receive treatment with investigational stem cells, the eligible patient must:

(1) be enrolled in a clinical trial investigating the use of adult stem cells in humans;

(2) sign a written informed consent, before receiving treatment, which includes documentation of compliance with § 1003.053(2)(a) of the Texas Health and Safety Code;

(3) receive treatment from a physician certified under § 1003.055 of the Texas Health and Safety Code by:
(A) a qualifying IRB;

(B) a medical school as defined by § 61.501 of the Education Code; or

(C) a hospital licensed under Chapter 241 of the Texas Health and Safety Code; and

(4) receive treatment in a qualifying facility under § 1003.055 of the Texas Health and Safety Code.

Disclaimer: These regulations may not be the most recent version. Texas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.